A narrative review for radiation oncologists to implement preoperative partial breast irradiation.
APBI
Early stage breast cancer
Preoperative radioablation
Preoperative radiotherapy
Journal
La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
13
03
2023
accepted:
16
08
2023
medline:
7
12
2023
pubmed:
31
8
2023
entrez:
31
8
2023
Statut:
ppublish
Résumé
The strategy to anticipate radiotherapy (RT) before surgery, for breast cancer (BC) treatment, has recently generated a renewed interest. Historically, preoperative RT has remained confined either to highly selected patients, in the context of personalized therapy, or to clinical research protocols. Nevertheless, in the recent years, thanks to technological advances and increased tumor biology understanding, RT has undergone great changes that have also impacted the preoperative settings, embracing the modern approach to breast cancer. In particular, the reappraisal of preoperative RT can be viewed within the broader view of personalized and tailored medicine. In fact, preoperative accelerated partial breast irradiation (APBI) allows a more precise target delineation, with less variability in contouring among radiation oncologists, and a smaller treatment volume, possibly leading to lower toxicity and to dose escalation programs. The aim of the present review, which represents a benchmark study for the AIRC IG-23118, is to report available data on different technical aspects of preoperative RT including dosimetric studies, patient's selection and set-up, constraints, target delineation and clinical results. These data, along with the ones that will become available from ongoing studies, may inform the design of the future trials and representing a step toward a tailored APBI approach with the potential to challenge the current treatment paradigm in early-stage BC.Trial registration: The study is registered at clinicaltrials.gov (NCT04679454).
Identifiants
pubmed: 37650981
doi: 10.1007/s11547-023-01706-6
pii: 10.1007/s11547-023-01706-6
doi:
Banques de données
ClinicalTrials.gov
['NCT04679454']
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1553-1570Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : AIRC under IG 2019 - ID. 23118
Informations de copyright
© 2023. Italian Society of Medical Radiology.
Références
Corradini S et al (2019) Preoperative radiotherapy: a paradigm shift in the treatment of breast cancer? A review of literature. Crit Rev Oncol Hematol 141:102–111
pubmed: 31272045
doi: 10.1016/j.critrevonc.2019.06.003
Bourgier C, Calvo FA, Marsiglia H, Martín M (2011) Overview of preoperative radiochemotherapy in breast cancer: past or future? Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 13:446–450
Deng Y et al (2021) Impact of preoperative vs postoperative radiotherapy on overall survival of locally advanced breast cancer patients. Front Oncol 11:779185
pubmed: 34888251
pmcid: 8650152
doi: 10.3389/fonc.2021.779185
Zhang Y, Xu Z, Chen H, Sun X, Zhang Z (2022) Survival comparison between postoperative and preoperative radiotherapy for stage I–III non-inflammatory breast cancer. Sci Rep 12:14288
pubmed: 35995985
pmcid: 9395522
doi: 10.1038/s41598-022-18251-3
Poleszczuk J et al (2017) Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Res BCR 19:75
pubmed: 28666457
doi: 10.1186/s13058-017-0870-1
Riet FG et al (2017) Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. Eur J Cancer Oxf Engl 1990(76):45–51
doi: 10.1016/j.ejca.2017.01.022
Coles CE, Fourquet A, Poortmans P (2017) Preoperative radiation therapy: the ‘new’ targeted breast cancer treatment? Eur J Cancer Oxf Engl 1990(78):116–117
doi: 10.1016/j.ejca.2017.03.027
Montero A, Ciérvide R (2022) Preoperative radio(chemo)therapy in breast cancer: time to switch the perspective? Curr Oncol Tor Oncol 29:9767–9787
doi: 10.3390/curroncol29120768
Bollet MA et al (2012) Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 102:82–88
doi: 10.1016/j.radonc.2011.08.017
Matuschek C et al (2020) Neoadjuvant Radio(chemo)therapy for breast cancer: an old concept revisited. Breast Care Basel Switz 15:112–117
doi: 10.1159/000507041
Preoperative Breast Irradiation-NCT02941835-ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/record/NCT02941835
Ciérvide R et al (2022) Primary chemoradiotherapy treatment (PCRT) for HER2+ and triple negative breast cancer patients: a feasible combination. Cancers 14:4531
pubmed: 36139688
pmcid: 9496977
doi: 10.3390/cancers14184531
Mulliez T et al (2022) Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study. Radiother Oncol J Eur Soc Ther Radiol Oncol 170:118–121
doi: 10.1016/j.radonc.2022.02.033
Yoo S, Blitzblau R, Yin F-F, Horton JK (2015) Dosimetric comparison of preoperative single-fraction partial breast radiotherapy techniques: 3D CRT, noncoplanar IMRT, coplanar IMRT, and VMAT. J Appl Clin Med Phys 16:5126
pubmed: 25679170
doi: 10.1120/jacmp.v16i1.5126
van der Leij F et al (2014) Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation. Radiother Oncol J Eur Soc Ther Radiol Oncol 110:467–470
doi: 10.1016/j.radonc.2013.10.033
Jagsi R et al (2010) Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76:71–78
pubmed: 19409733
pmcid: 4414125
doi: 10.1016/j.ijrobp.2009.01.041
Nichols EM et al (2010) Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future. Int J Radiat Oncol Biol Phys 77:197–202
pubmed: 20394853
doi: 10.1016/j.ijrobp.2009.04.063
Palta M, Yoo S, Adamson JD, Prosnitz LR, Horton JK (2012) Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 82:37–42
pubmed: 21093166
doi: 10.1016/j.ijrobp.2010.09.041
Nichols EM et al (2013) Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy. Am J Clin Oncol 36:232–238
pubmed: 22549267
doi: 10.1097/COC.0b013e3182467ffd
Palma DA, Louie AV, Rodrigues GB (2015) New strategies in stereotactic radiotherapy for oligometastases. Clin Cancer Res Off J Am Assoc Cancer Res 21:5198–5204
doi: 10.1158/1078-0432.CCR-15-0822
Lischalk JW et al (2018) Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors. Adv Radiat Oncol 3:447–457
pubmed: 30202812
pmcid: 6128030
doi: 10.1016/j.adro.2018.05.002
Charaghvandi RK et al (2015) MRI-guided single fraction ablative radiotherapy for early-stage breast cancer: a brachytherapy versus volumetric modulated arc therapy dosimetry study. Radiother Oncol J Eur Soc Ther Radiol Oncol 117:477–482
doi: 10.1016/j.radonc.2015.09.023
Charaghvandi KR et al (2019) Single dose partial breast irradiation using an MRI linear accelerator in the supine and prone treatment position. Clin Transl Radiat Oncol 14:1–7
pubmed: 30406210
Kirby AM (2018) Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial? Br J Radiol 91:20170565
pubmed: 29513031
pmcid: 6190767
doi: 10.1259/bjr.20170565
Campos Magalhães Garcia LS, Garcia Trigo ML (2021) Results of accelerated partial breast irradiation in patients not suitable for external beam irradiation stratified by GEC-ESTRO, ASTRO, and ABS guidelines. Brachytherapy 20:315–325
pubmed: 33199176
doi: 10.1016/j.brachy.2020.10.005
Meattini I et al (2022) European Society for radiotherapy and oncology advisory committee in radiation oncology practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol 23:e21–e31
pubmed: 34973228
doi: 10.1016/S1470-2045(21)00539-8
Blitzblau RC et al (2015) A phase 1 trial of preoperative partial breast radiation therapy: Patient selection, target delineation, and dose delivery. Pract Radiat Oncol 5:e513–e520
pubmed: 25834942
pmcid: 4568137
doi: 10.1016/j.prro.2015.02.002
Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R (1989) Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol J Eur Soc Ther Radiol Oncol 16:253–267
doi: 10.1016/0167-8140(89)90037-6
Thomas F et al (1988) Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis. Radiother Oncol J Eur Soc Ther Radiol Oncol 13:267–276
doi: 10.1016/0167-8140(88)90222-8
Tiberi D et al (2020) Tumour response 3 months after neoadjuvant single-fraction radiotherapy for low-risk breast cancer. Curr Oncol Tor Ont 27:155–158
doi: 10.3747/co.27.6059
Nichols E et al (2017) Preoperative accelerated partial breast irradiation for early-stage breast cancer: preliminary results of a prospective, phase 2 trial. Int J Radiat Oncol Biol Phys 97:747–753
pubmed: 28244410
doi: 10.1016/j.ijrobp.2016.11.030
Boughey JC et al (2014) Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg 260:608–614; discussion 614–616
Thomssen C, Balic M, Harbeck N, Gnant M (2021) St. Gallen/Vienna 2021: a brief summary of the consensus discussion on customizing therapies for women with early breast cancer. Breast Care 16:135–143
pubmed: 34002112
pmcid: 8089428
doi: 10.1159/000516114
Guidolin K et al (2019) Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy. Curr Oncol Tor Oncol 26:e334–e340
doi: 10.3747/co.26.4479
Sardanelli F et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer Oxf Engl 1990(46):1296–1316
doi: 10.1016/j.ejca.2010.02.015
Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol Off J Am Soc Clin Oncol 24:3293–3298
doi: 10.1200/JCO.2006.06.8080
den Hartogh MD et al (2014) MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy. Radiat Oncol Lond Engl 9:63
doi: 10.1186/1748-717X-9-63
Charaghvandi RK et al (2017) Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol. BMC Cancer 17:181
pubmed: 28274211
pmcid: 5343419
doi: 10.1186/s12885-017-3144-5
Meattini I et al (2022) Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894). Clin Transl Radiat Oncol 37:94–100
pubmed: 36177053
pmcid: 9513617
Di Pasquale Guadalupe L, De Jesús J, Xiong Y, Rosa M (2020) Tumor size and focality in breast carcinoma: analysis of concordance between radiological imaging modalities and pathological examination at a cancer center. Ann Diagn Pathol 48:151601
pubmed: 32871502
doi: 10.1016/j.anndiagpath.2020.151601
Bondiau P-Y et al (2013) Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. Int J Radiat Oncol Biol Phys 85:1193–1199
pubmed: 23332384
doi: 10.1016/j.ijrobp.2012.10.034
NSABP B-39, RTOG 0413 (2006) A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol HO 4:719–721
Snider JW et al (2017) Dosimetric improvements with a novel breast stereotactic radiotherapy device for delivery of preoperative partial-breast irradiation. Oncology 92:21–30
pubmed: 27898429
doi: 10.1159/000449388
Bondiau P-Y et al (2009) Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys 75:1041–1047
pubmed: 19386428
doi: 10.1016/j.ijrobp.2008.12.037
Yamada Y, Ackerman I, Franssen E, MacKenzie RG, Thomas G (1999) Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys 44:99–104
pubmed: 10219801
doi: 10.1016/S0360-3016(98)00507-0
Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G (1985) Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave–Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 11:1751–1757
pubmed: 4044337
doi: 10.1016/0360-3016(85)90027-6
Horton JK et al (2015) Preoperative single-fraction partial breast radiation therapy: a novel phase 1, Dose-escalation protocol with radiation response biomarkers. Int J Radiat Oncol Biol Phys 92:846–855
pubmed: 26104938
pmcid: 4481883
doi: 10.1016/j.ijrobp.2015.03.007
Wang C, Horton JK, Yin F-F, Chang Z (2016) Assessment of treatment response with diffusion-weighted MRI and dynamic contrast-enhanced MRI in patients with early-stage breast cancer treated with single-dose preoperative radiotherapy: initial results. Technol Cancer Res Treat 15:651–660
pubmed: 26134438
doi: 10.1177/1533034615593191
Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18:234–239
pubmed: 18725109
pmcid: 2750078
doi: 10.1016/j.semradonc.2008.04.004
Benedict SH et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078–4101
pubmed: 20879569
doi: 10.1118/1.3438081
Marks LB et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10-19
pubmed: 20171502
pmcid: 4041542
doi: 10.1016/j.ijrobp.2009.07.1754
Rahimi A et al (2017) Preliminary results of a phase 1 Dose-escalation trial for early-stage breast cancer using 5-fraction stereotactic body radiation therapy for partial-breast irradiation. Int J Radiat Oncol Biol Phys 98:196-205.e2
pubmed: 28586960
doi: 10.1016/j.ijrobp.2017.01.020
Olivotto IA et al (2013) Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol Off J Am Soc Clin Oncol 31:4038–4045
doi: 10.1200/JCO.2013.50.5511
Hepel JT et al (2009) Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75:1290–1296
pubmed: 19395195
doi: 10.1016/j.ijrobp.2009.01.009
Pinnarò P et al (2011) Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol Lond Engl 6:155
doi: 10.1186/1748-717X-6-155
Lei RY et al (2013) Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat 140:119–133
pubmed: 23824363
pmcid: 3706719
doi: 10.1007/s10549-013-2623-x
Rahimi A et al (2020) Risk factors for fat necrosis after stereotactic partial breast irradiation for early-stage breast cancer in a phase 1 clinical trial. Int J Radiat Oncol Biol Phys 108:697–706
pubmed: 32464155
doi: 10.1016/j.ijrobp.2020.05.025
Natarajan B et al (2018) Findings on surveillance imaging after preoperative partial breast irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 102:1374–1381
pubmed: 30170870
pmcid: 6202155
doi: 10.1016/j.ijrobp.2018.05.059
Timmerman RD (2008) An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 18:215–222
pubmed: 18725106
doi: 10.1016/j.semradonc.2008.04.001
Folkert MR, Timmerman RD (2017) Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT). Adv Drug Deliv Rev 109:3–14
pubmed: 27932046
doi: 10.1016/j.addr.2016.11.005
Deutsch M (2002) Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 53:687–691
pubmed: 12062613
doi: 10.1016/S0360-3016(02)02785-2
Wu H et al (2018) Short-course radiotherapy with immediate or delayed surgery in rectal cancer: a meta-analysis. Int J Surg Lond Engl 56:195–202
doi: 10.1016/j.ijsu.2018.05.031
Ngo M-H et al (2020) Abstract P4–12-07: single pre-operative radiation therapy (SPORT) trial for low risk breast cancer: a phase 1 study comparing pathological findings in immediate versus delayed surgery. Cancer Res 80:P4-P4-12-07
doi: 10.1158/1538-7445.SABCS19-P4-12-07
Vasmel JE et al (2020) Tumor response after neoadjuvant magnetic resonance guided single ablative dose partial breast irradiation. Int J Radiat Oncol Biol Phys 106:821–829
pubmed: 31812720
doi: 10.1016/j.ijrobp.2019.11.406
Bosma SCJ et al (2020) Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial. Int J Radiat Oncol Biol Phys 106:958–967
pubmed: 31987957
doi: 10.1016/j.ijrobp.2019.12.037
Li X-R et al (2012) DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol Northwood Lond Engl 29:425–431
doi: 10.1007/s12032-011-9842-y
Padhani AR (2011) Diffusion magnetic resonance imaging in cancer patient management. Semin Radiat Oncol 21:119–140
pubmed: 21356480
doi: 10.1016/j.semradonc.2010.10.004
Lv G et al (2020) Comparison of model-free and model-based dynamic contrast-enhanced magnetic resonance imaging pharmacokinetic parameters for predicting breast cancers’ response to neoadjuvant chemotherapy. J Comput Assist Tomogr 44:269–274
pubmed: 32195807
doi: 10.1097/RCT.0000000000001001
Weinfurtner RJ et al (2022) MRI response to pre-operative stereotactic ablative body radiotherapy (SABR) in early stage ER/PR+ HER2-breast cancer correlates with surgical pathology tumor bed cellularity. Clin Breast Cancer 22:e214–e223
pubmed: 34384695
doi: 10.1016/j.clbc.2021.06.016
Ho AY et al (2020) A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer. Cancer 126:850–860
pubmed: 31747077
doi: 10.1002/cncr.32599
Barroso-Sousa R et al (2020) A phase II study of pembrolizumab in combination with palliative radiotherapy for hormone receptor-positive metastatic breast cancer. Clin Breast Cancer 20:238–245
pubmed: 32113750
doi: 10.1016/j.clbc.2020.01.012
McArthur HL, Page DB (2016) Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy. Clin Adv Hematol Oncol HO 14:922–933
Disis ML, Stanton SE (2018) Immunotherapy in breast cancer: an introduction. Breast Edinb Scotl 37:196–199
doi: 10.1016/j.breast.2017.01.013
Bertucci F, Gonçalves A (2017) Immunotherapy in breast cancer: the emerging role of PD-1 and PD-L1. Curr Oncol Rep 19:64
pubmed: 28799073
doi: 10.1007/s11912-017-0627-0
Nathan MR, Schmid P (2018) The emerging world of breast cancer immunotherapy. Breast Edinb Scotl 37:200–206
doi: 10.1016/j.breast.2017.05.013
Ho AY et al (2020) Optimizing radiation therapy to boost systemic immune responses in breast cancer: a critical review for breast radiation oncologists. Int J Radiat Oncol Biol Phys 108:227–241
pubmed: 32417409
pmcid: 7646202
doi: 10.1016/j.ijrobp.2020.05.011
Mukai H et al (2013) Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306. Oncology 85:336–341
pubmed: 24247597
doi: 10.1159/000355196
Kuerer HM et al (2022) Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol 23:1517–1524
pubmed: 36306810
doi: 10.1016/S1470-2045(22)00613-1
Bosma SCJ et al (2020) Response to preoperative radiation therapy in relation to gene expression patterns in breast cancer patients. Int J Radiat Oncol Biol Phys 106:174–181
pubmed: 31525407
doi: 10.1016/j.ijrobp.2019.09.002
Lightowlers SV et al (2017) Preoperative breast radiation therapy: indications and perspectives. Eur J Cancer Oxf Engl 1990(82):184–192
doi: 10.1016/j.ejca.2017.06.014